Global Animal Vaccines Market likely to grow at a CAGR of 7.4% in the forecast period of 2021-2026

According to the MarkNtel Advisors research report, "Global Animal Vaccines Market Analysis, 2021," the market is likely to grow at a CAGR of 7.4% in the forecast period of 2021-26. The expanding concerns for food security & animal husbandry are raising the demand for vaccines for the livestock population. Moreover, the burgeoning requirement for animal products like milk, eggs, chicken, and meat is prompting farmers to adopt vaccinations for their livestock and attain greater profitability.

Get a sample copy of the market research: https://www.marknteladvisors.com/query/request-sample/global-animal-vaccine-market.html

Key questions answered in the study
1. What are the current and future trends in the Global Animal Vaccines Market?
2. How has the industry been evolving in terms of geography and services adoption?
3. How has the competition been shaping across the countries, followed by their comparative factorial indexing?
4. What are the key growth drivers & challenges for the Global Animal Vaccines Market?
5. What are the customer orientation, purchase behavior, and expectations from the Global Animal Vaccines Market service providers across various regions?

Poultry Vaccine Exhibits Fastest Growth

Based on the type of vaccines, the market segments into Porcine Vaccines, Aquaculture Vaccines, Ruminants Vaccines, Companion Animals Vaccines (Canine Vaccines, Feline Vaccines, Poultry Vaccines), and Livestock Vaccines. From the type, the Poultry Vaccine is likely to exhibit the fastest growth rate in the forecast period. It owes to the massive consumption of poultry products daily by a large part of the population. There shall be approximately a 20% increase in the demand for poultry products in the forecast years and propel the demand for poultry vaccines. Furthermore, using a wide range of vaccines & pharmaceuticals to yield high-quality poultry products is another critical factor likely to broaden the scope for the segment growth.

Porcine Disease to Attain Largest Market Share

Based on the disease, the Global Animal Vaccine Market segments into Porcine Diseases, Aquaculture Diseases, Ruminants Diseases, Companion Animals Diseases (Canine Diseases, Feline Diseases), Poultry Diseases, and Livestock Diseases. In the previous few years, the Porcine Disease segment dominated this market prominently owing to the high & growing prevalence of various infections and the surging awareness of vaccines among the population. Hence, the market is likely to witness massive demand from multiple countries, especially from the Asia-Pacific region, and shall drive the market to attain the largest share in the forecast period.

For detailed analysis visit: https://www.marknteladvisors.com/research-library/global-animal-vaccine-market.html

"Global Animal Vaccines Market Analysis, 2021" provides comprehensive, qualitative, and quantitative insights on the market potential, key factors impacting the market growth, hotspots, and opportunities available for Animal Vaccine providers across the globe. Moreover, the report also encompasses the key strategic imperatives for competitors' success and strategic factorial indexing to measure their capabilities on 16 parameters, which will help companies formulate 'Go to Market' strategies and identify the blue ocean for their offerings.

According to MarkNtel Advisors, the leading players in the Global Animal Vaccines Market are Elanco, Ceva, Phibro Animal Health Corporation, Neogen Corporation, Intas Pharmaceuticals Ltd., Biogénesis Bagó, Ourofino Saúde Animal, Virbac, Zoetis, Merc & Co., Inc., Boehringer Ingelheim International GmbH.

Market Segmentation:
1. By Type (Porcine Vaccines, Aquaculture Vaccines, Ruminants Vaccines, Companion Animals Vaccines (Canine Vaccines, Feline Vaccines, Poultry Vaccines), Livestock Vaccines)
2. By Diseases (Porcine Diseases, Aquaculture Diseases, Ruminants Diseases,
3. Companion Animals Diseases (Canine Diseases, Feline Diseases), Poultry Diseases, Livestock Diseases)
4. By Technology (Live Attenuated Vaccines, Livestock Inactivated Vaccines, Toxoid Vaccine, Recombinant Vaccines, Other (DNA vaccines))
5. By Region (North America, Latin America, Europe, Asia-Pacific, Middle East, and Africa)
6. By Competitors (Elanco, Ceva, Phibro Animal Health Corporation, Neogen Corporation, Intas Pharmaceuticals Ltd., Biogénesis Bagó, Ourofino Saúde Animal, Virbac, Zoetis, Merc & Co., Inc., Boehringer Ingelheim International GmbH)

MarkNtel Advisors
1147 88AVE, Delta, British Columbia, BC,V4C,3B8, CANADA
Email: sales@marknteladvisors.com
Tel: +1613-707-5086
Website: https://www.marknteladvisors.com

MarkNtel Advisors is a leading research, consulting and data analytics firm that provides a wide range of strategic reports on diverse industry verticals to a substantial and varied client base that includes multinational corporations, financial institutions, governments, and individuals.

We specialize in niche industries and emerging geographies to support our clients in the formulation of strategies viz. Go to Market (GTM), product development, feasibility analysis, project scoping, market segmentation, competitive benchmarking, market sizing & forecasting, trend analysis, etc. in around 15 industry verticals to enable our clients in identifying attractive investment opportunities and maximizing ROI through an early mover advantage.

This release was published on openPR.